ANNA HURLEY: Open Payments
NPI 1902444045 · DANBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,411 in 52 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $1,514 · 2025 $1,411
Food & beverage: $1,411
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $426 |
| AstraZeneca Pharmaceuticals LP | 6 | $266 |
| Amgen Inc. | 5 | $172 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $104 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $94 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $65 |
| Astellas Pharma US Inc | 2 | $56 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Corcept Therapeutics | 1 | $25 |
Products named: BREZTRI, VRAYLAR, CREON, AIRSUPRA, UBRELVY, Kerendia, TRINTELLIX, XIFAXAN.
Industry payments across CT — which companies pay providers there.
